TeleheartCR vs. Clinic-Based Cardiac Rehabilitation After Acute Coronary Syndrome
Comparing a Novel Telehealth-enabled Hybrid Cardiac Rehabilitation Program to Clinic-based Cardiac Rehabilitation for Improving Patient Engagement and Functional Outcomes After ACS
2 other identifiers
interventional
250
1 country
1
Brief Summary
Cardiac rehabilitation (CR) is an effective evidence-based intervention that improves outcomes in patients with acute coronary syndrome (ACS), but many eligible patients do not complete the program. A hybrid CR intervention that combines telehealth, home-based, and clinic-based components (TeleheartCR) may increase participation by addressing barriers to access while maintaining the functional capacity benefits of traditional CR. The purpose of this study is to conduct a randomized controlled trial comparing TeleheartCR with traditional clinic-based CR in patients with ACS to evaluate differences in program adherence and pre-to-post program change in functional capacity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2026
CompletedFirst Submitted
Initial submission to the registry
April 15, 2026
CompletedFirst Posted
Study publicly available on registry
April 21, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2029
April 21, 2026
April 1, 2026
3.1 years
April 15, 2026
April 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Proportion of targeted sessions completed (Program Adherence)
Defined as the proportion of targeted cardiac rehabilitation (CR) sessions completed in each arm. Adherence will be calculated as the number of completed CR sessions divided by 36 (range: 0 to 1).
During the cardiac rehabilitation program (up to 6 months)
Change in 6-Minute Walk Test Distance
Functional capacity will be assessed using the 6-minute walk test (6MWT), which measures the total distance walked in meters over six minutes. Change in functional capacity will be calculated as the difference between post-program and baseline 6MWT distance.
Baseline and end of program (up to 6 months)
Secondary Outcomes (4)
Mean Acceptability of Intervention Measure Score (Program Acceptability)
End of program (up to 6 months)
Mean Intervention Appropriateness Measure Score (Program Appropriateness)
End of program (up to 6 months)
Change in Health-Related Quality of Life Score
Baseline and end of program (up to 6 months)
Change in METs Achieved During Exercise Testing
Baseline and end of program (up to 6 months)
Study Arms (2)
TeleheartCR
EXPERIMENTALParticipants will receive Telehealth-enhanced Hybrid Cardiac Rehabilitation Program
Traditional CR
ACTIVE COMPARATORParticipants will receive Traditional Clinic-based Cardiac Rehabilitation Program
Interventions
The telehealth-enhanced hybrid cardiac rehabilitation program combines in-person, clinic-based sessions with virtual, home-based sessions. Home-based sessions are delivered via synchronous video visits, with supervision by trained staff and real-time monitoring of physiological data (e.g., heart rate and blood pressure). The program delivers standard components of cardiac rehabilitation, including aerobic and resistance exercise training and patient education on heart-healthy lifestyle behaviors and risk factor management. Participants receive structured, program-specific orientation and training early in the program to support safe participation in virtual home-based sessions. The intervention is digitally enabled and incorporates an integrated system designed to guide and structure participation in program activities. The program includes up to 36 sessions, including a combination of clinic-based and home-based sessions.
The traditional cardiac rehabilitation program is delivered in person through clinic-based sessions according to standard-of-care protocols. Sessions are supervised by trained staff and include aerobic and resistance exercise training, as well as patient education and counseling on heart-healthy lifestyle behaviors and risk factor management. The program includes up to 36 clinic-based sessions delivered according to standard-of-care practice.
Eligibility Criteria
You may qualify if:
- Age 18 years or older
- Diagnosis of acute coronary syndrome within the past 12 months
- Eligible for outpatient cardiac rehabilitation
- Able to read and speak English or Spanish
- Resides in New York State
You may not qualify if:
- Severe medical or psychiatric comorbidities that would prevent safe or adequate participation
- High risk for adverse exercise-related cardiovascular events
- Initiation of cardiac rehabilitation prior to enrollment (i.e., \>1 session completed)
- Conditions that would interfere with safe or consistent participation in study procedures
- Home environment or willingness not compatible with safe or adequate participation
- Not expected to be available for follow-up during the study period
- Current participation in another interventional clinical trial that may affect study outcomes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Columbia University Irving Medical Center
New York, New York, 10032, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrea T. Duran, PhD
Columbia University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Masking Details
- The principal investigator and senior statistician will remain blinded to treatment allocation until the database is locked. Participants, care providers, and outcome assessors will not be blinded.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Medical Sciences
Study Record Dates
First Submitted
April 15, 2026
First Posted
April 21, 2026
Study Start
April 1, 2026
Primary Completion (Estimated)
May 1, 2029
Study Completion (Estimated)
May 1, 2029
Last Updated
April 21, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- ANALYTIC CODE
- Time Frame
- Data will be made available after publication of the primary study results and will remain available for at least 10 years thereafter.
- Access Criteria
- De-identified data will be made publicly available via an open-access repository. No personally identifiable information will be shared.
De-identified individual participant data (IPD) will be shared, including demographic, clinical, and outcome data underlying the results reported in publications.